Registration number: 12457690

Novai Ltd

Contents

Balance Sheet	1 to 2
Notes to the Unaudited Financial Statements	3 to 8

Novai Ltd

(Registration number: 12457690)
Balance Sheet as at 31 March 2026

	Note	2026 £	2025 £
Fixed assets
Intangible assets	4	1,693,316	1,958,876
Tangible assets	5	52,751	71,575
		1,746,067	2,030,451
Current assets
Stocks	6	722,937	787,265
Debtors	7	43,454	193,495
Cash at bank and in hand		255,888	38,081
		1,022,279	1,018,841
Creditors: Amounts falling due within one year	8	(2,281,230)	(2,778,152)
Net current liabilities		(1,258,951)	(1,759,311)
Total assets less current liabilities		487,116	271,140
Creditors: Amounts falling due after more than one year	8	(162,500)	(159,374)
Net assets		324,616	111,766
Capital and reserves
Called up share capital		6	6
Share premium reserve		4,847,879	4,585,978
Other reserves		995,164	-
Retained earnings		(5,518,433)	(4,474,218)
Shareholders' funds		324,616	111,766

Novai Ltd

(Registration number: 12457690)
Balance Sheet as at 31 March 2026

For the financial year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 6 October 2026 and signed on its behalf by:
 

......................................... Prof M F Cordeiro Director

Novai Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026

1	General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
9 Greyfriars Road
Reading
Berkshire
RG1 1NU
United Kingdom

2	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Revenue on clinical and pre-clinical projects is recognised by reference to the proportion of product or services delivered to determine the stage of work completed on the project.

Rental Income occurs where the Company provides imaging equipment in connection with the client projects and is recognised on a straight line basis across the duration of the operating lease agreement. Where equipment is sold to the client the turnover comprises the fair value of the consideration received or receivable.

Revenue on grants is recognised on the basis of the accruals concept.

Prize and competition income is recorded as Other Income when received.

Turnover is shown net of sales/value added tax, returns, rebates and discounts.

Tax

The tax expense for the period comprises current tax payable.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Novai Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026

Tangible assets

Tangible fixed assets held for the company's own use are stated at cost less accumulated depreciation and accumulated impairment losses.

Depreciation is calculated on a straight-line basis based on the asset class such as office equipment or machinery. Assets held under finance leases are depreciated in the same way as owned assets.

Asset impairment reviews are performed on an ad-hoc basis when reports of potential damages to the asset are received. If any such indication exists, the recoverable amount of an asset is estimated to determine the extent of the impairment loss, if any. Where it is not possible to estimate the recoverable amount of the asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Computer equipment	5 years straight line basis
Office equipment	7 years straight line basis
Plant and machinery	5 years straight line basis

Research and development

In the research phase of an internal project, it is not possible to demonstrate that the project will generate future economic benefits and hence all expenditure on research is recognised as an expense when it is incurred. Intangible assets are recognised from the development phase of a project if and only if certain specific criteria are met to demonstrate the asset will generate probable future economic benefits and that its cost can be reliably measured.

The capitalised development costs are subsequently amortised to administrative expenses on a straight-line basis over their expected useful economic lives. Amortisation begins when the intangible asset is available for use, i.e., when it is in the location and condition necessary for it to be usable in the manner intended by management.

The expected useful economic lives of development costs are estimated based on business plans which set out the development plan and time to market for the associated project.

If it is not possible to distinguish between the research phase and the development phase of an internal project the expenditure is treated as if it were all incurred in the research phase only.
 

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life commencing from the period when the asset becomes available for use and is able to generate economic benefits.

Asset class	Amortisation method and rate
Research and development costs	10 years straight line basis

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Debtors

Trade debtors are amounts due from customers for services performed in the ordinary course of business.

Novai Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell (net realisable value). Costs, which comprise direct production costs, are based on the method most appropriate to the type of inventory class, but usually on a first-in-first-out basis. Overheads are charged to the profit or loss as incurred. Net realisable value is based on the estimated selling price less any estimated completion or selling costs.

When stocks are sold, the carrying amount of those stocks is recognised as an expense in cost of sales, in the period in which the related revenue is recognised. The amount of any write-down of stocks to net realisable value and all losses of stocks are recognised as an expense in the period in which the write-down or loss occurs. The amount of any reversal of any write-down of stocks is recognised as a reduction in the number of stocks recognised as an expense in the period in which the reversal occurs.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the Profit and Loss Account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3	Staff numbers

The average number of persons employed by the company (including directors) during the year, was 11 (2025 - 14).

Novai Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026

4	Intangible assets

	Research and development costs  £	Total £
Cost or valuation
At 1 April 2025	1,958,876	1,958,876
Transfers	(77,414)	(77,414)
At 31 March 2026	1,881,462	1,881,462
Amortisation charge	188,146	188,146
At 31 March 2026	188,146	188,146
Carrying amount
At 31 March 2026	1,693,316	1,693,316
At 31 March 2025	1,958,876	1,958,876

5	Tangible assets

	Plant and machinery £	Office equipment £	Computer equipment £	Total £
Cost or valuation
At 1 April 2025	155,632	3,831	30,722	190,185
Additions	-	-	125	125
Disposals	(155,632)	-	-	(155,632)
Transfers	77,414	-	-	77,414
At 31 March 2026	77,414	3,831	30,847	112,092
Depreciation
At 1 April 2025	93,379	2,792	22,439	118,610
Charge for the year	36,167	310	5,415	41,892
Eliminated on disposal	(101,161)	-	-	(101,161)
At 31 March 2026	28,385	3,102	27,854	59,341
Carrying amount
At 31 March 2026	49,029	729	2,993	52,751
At 31 March 2025	62,253	1,039	8,283	71,575

Novai Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026

6

Stocks

	2026 £	2025 £
Other inventories	722,937	787,265

7

Debtors

Current	2026 £	2025 £
Trade debtors	-	167,160
Prepayments	17,429	18,260
Other debtors	26,025	8,075
	43,454	193,495

8

Creditors

Creditors: amounts falling due within one year

	Note	2026 £	2025 £
Due within one year
Loans and borrowings	11	71,758	116,081
Trade creditors		865,585	710,522
Amounts due to related parties	12	499,930	309,423
Social security and other taxes		26,920	8,562
Pension contributions payable		6,757	5,433
Other payables		15,727	502,590
Accruals and deferred income		794,553	1,102,623
Income tax liability		-	22,918
		2,281,230	2,778,152
Due after one year
Loans and borrowings	11	162,500	159,374

Novai Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026

9	Obligations under leases and hire purchase contracts

Operating leases

The total of future minimum lease payments is as follows:

	2026 £	2025 £
Not later than one year	16,748	13,916

10

Reserves

The company receives advance subscription funds (ASAs) and has issued contingent value rights (CVRs).

The ASAs are non-refundable and convertible into equity shares. As at 31 March 2026 the shares had not yet been allotted and accordingly the balance has been presented in equity as an ASA reserve.

The CVRs are rights to receive a contingent equity allotment when a triggering event occurs with no obligation to be settled in cash. As at 31 March 2026 no allotment had been made and accordingly the balance has been presented in equity as a CVR reserve.

11	Loans and borrowings

Current loans and borrowings

	2026 £	2025 £
Bank borrowings	71,758	80,328
Bank overdrafts	-	35,753
	71,758	116,081

Non-current loans and borrowings

	2026 £	2025 £
Bank borrowings	87,500	159,374
Other borrowings	75,000	-
	162,500	159,374

12	Related party transactions

Other transactions with directors

Prof M F Cordeiro (director), made a loan to the company. At the balance sheet date the amount due to Prof M F Cordeiro was £499,930 (2025: £309,423).